SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?


To: Ian@SI who wrote (988)8/2/2000 9:42:36 PM
From: Ian@SI  Read Replies (1) | Respond to of 1321
 
08/02 09:20
QLT Inc. Reiterated `Strong Buy' at Deutsche Banc AB QLT Inc. (QLTI US) was reiterated ``strong buy'' by analyst Kevin C. Tang at Deutsche Banc Alex. Brown. The 12-month target price is $102.00 per share.

08/02 09:19
QLT Maintained `Top Pick' at Nesbitt Burns QLT Inc. (QLT CN) was maintained ``top pick'' by analyst Christine Charette at Nesbitt Burns. The 12-month target price raised to C$150.00 from C$125.00 per share.

08/02 09:07
QLT Maintained `Outperform' at RBC Dominion QLT Inc. (QLT CN) was maintained ``outperform'' by analyst Douglas Miehm at RBC Dominion Securities. The 12-month target price raised to C$135.00 from C$125.00 per share.

+++++++++++++